Physician profile
Jared Michael Cox
NPI 1942410386
$11,536.18
in general payments reported to CMS, 2019-2025
48 companies · $3,550 in 2025
The $3,550 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,723 · 2020: $495 · 2021: $967 · 2022: $1,322 · 2023: $1,314 · 2024: $1,166 · 2025: $3,550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,449 · Consulting Fee: $1,580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,449.46 |
| Consulting Fee | $1,580.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,819.61 | 2019-2025 | Adstiladrin |
| Neotract INC. | $1,324.76 | 2019 | |
| Abbvie INC. | $1,278.26 | 2019-2025 | Botox |
| Sumitomo Pharma America, INC. | $1,174.24 | 2023-2025 | Gemtesa, Orgovyx |
| Allergan, INC. | $742.65 | 2019-2022 | |
| Astellas Pharma US INC | $575.72 | 2019-2025 | Myrbetriq, Xtandi, Veozah |
| Janssen Biotech, INC. | $414.69 | 2019-2025 | Erleada |
| Coloplast Corp | $363.35 | 2019-2025 | Porges Coloplast, Vortek Hydro, Speedicath |
| Antares Pharma, INC. | $276.21 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Urovant Sciences INC | $271.06 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $266.24 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Bioprotect Medical, INC. | $265.90 | 2025 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $254.05 | 2019-2024 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $212.06 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Dendreon Pharmaceuticals LLC | $172.66 | 2019-2021 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.